OPT2MISE STUDY: THE IMPACT OF INSULIN PUMP THERAPY ON TREATMENT SATISFACTION AND RESOURCE UTILIZATION IN PATIENTS WITH TYPE 2 DIABETES

被引:0
|
作者
Aronson, R. [1 ]
De Portu, S. [2 ]
Cohen, O. [3 ]
Conget, I. [4 ]
Racault, A. S. [2 ]
Shin, J. [5 ]
Runzis, S. [2 ]
Reznik, Y. [6 ]
机构
[1] LMC Diabet & Endocrinol, Toronto, ON, Canada
[2] Medtron Int Trading Sarl, Dept Diabet, Tolochenaz, Switzerland
[3] Chaim Sheba Med Ctr, Inst Endocrinol, IL-52621 Tel Hashomer, Israel
[4] Univ Hosp Clin, Dept Endocrinol & Diabet, Barcelona, Spain
[5] Medtron Diabet, Dept Diabet, Northridge, CA USA
[6] CHU Cote Nacre, Dept Endocrinol & Diabet, Caen, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
26
引用
收藏
页码:A11 / A11
页数:1
相关论文
共 50 条
  • [1] OpT2mise study: the impact of insulin pump therapy on treatment satisfaction and resource utilisation in patients with type 2 diabetes
    Aronson, R.
    Cohen, O.
    Conget, I.
    de Portu, S.
    Racault, A-S.
    Shin, J.
    Reznik, Y.
    DIABETOLOGIA, 2014, 57 : S415 - S415
  • [2] Efficacy and safety of insulin pump therapy in type 2 diabetes: the OpT2mise study
    Reznik, Y.
    Cohen, O.
    Aronson, R.
    Runzis, S.
    Castaneda, J.
    De Portu, S.
    Lee, S.
    Conget, I.
    DIABETOLOGIA, 2014, 57 : S410 - S411
  • [3] Efficacy and Safety of Insulin Pump Therapy in Type 2 Diabetes: The OpT2mise Study
    Aronson, Ronnie
    Reznik, Yves
    Conget, Ignacio
    Runzis, Sarah
    Castaneda, Javier
    De Portu, Simone
    Lee, Scott
    Cohen, Ohad
    DIABETES, 2015, 64 : A270 - A271
  • [4] The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study
    Conget, Ignacio
    Castaneda, Javier
    Petrovski, Goran
    Guerci, Bruno
    Racault, Anne-Sophie
    Reznik, Yves
    Cohen, Ohad
    Runzis, Sarah
    de Portu, Simona
    Aronson, Ronnie
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (01) : 22 - 28
  • [5] The impact of insulin pump therapy on glycaemic profile of patients with type 2 diabetes: data from the OpT2mise study
    Conget, I.
    Cohen, O.
    Aronson, R.
    Castaneda, J.
    Re, R.
    Shin, J.
    Reznik, Y.
    DIABETOLOGIA, 2014, 57 : S416 - S416
  • [6] THE IMPACT OF INSULIN PUMP THERAPY ON GLYCEMIC PROFILE OF PATIENTS WITH TYPE 2 DIABETES. DATA FROM THE OPT2MISE STUDY
    Conget, I.
    Cohen, O.
    Aronson, R.
    Castaneda, J.
    Runzis, S.
    Huang, S.
    Shin, J.
    Reznik, Y.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A33 - A33
  • [7] EFFICACY AND SAFETY OF INSULIN PUMP THERAPY IN TYPE 2 DIABETES: OPT2MISE STUDY - FULL STUDY REPORT
    Aronson, R.
    Reznik, Y.
    Conget, I.
    Runzis, S.
    De Portu, S.
    Lee, S.
    Castaneda, J.
    Cohen, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A41 - A41
  • [8] Contribution of basal and postprandial hyperglycaemia in type 2 diabetes patients treated by an intensified insulin regimen: Impact of pump therapy in the OPT2mise trial
    Reznik, Yves
    Habteab, Aklilu
    Castaneda, Javier
    Shin, John
    Joubert, Michael
    DIABETES OBESITY & METABOLISM, 2018, 20 (10): : 2435 - 2441
  • [9] OPT2MISE: A RANDOMISED CONTROLLED TRIAL TO COMPARE INSULIN PUMP THERAPY WITH MULTIPLE DAILY INJECTIONS IN THE TREATMENT OF TYPE 2 DIABETES
    Reznik, Y.
    Cohen, O.
    Aronson, R.
    Conget, I.
    Runzis, S.
    Castaneda, J.
    Lee, S. W.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A33 - A33
  • [10] Efficacy and safety after 1 year of insulin pump therapy in type 2 diabetes: the OpT2mise Study continuation phase
    Reznik, Y.
    Aronson, R.
    Conget, I.
    Runzis, S.
    Racault, A. -S.
    Castaneda, J.
    Lee, S. W.
    Cohen, O.
    DIABETOLOGIA, 2015, 58 : S477 - S478